10 Leukemia Clinical Trials in Charlotte, MI (2026)

Q: How do I join a clinical trial in Charlotte?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Charlotte research site will contact you.

Recruiting Leukemia Studies in Charlotte

NCT06043817Recruiting

First-In-Human Study of STX-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations

Study STX-721-101 is an open label, Phase 1/2 study evaluating the safety, tolerability, pharmacokinetic (PK) exposure, and preliminary antitumor activity of STX-721 in participants with non-small cel...

Charlotte, MI345 participantsAntares Therapeutics, Inc

View Study Details

NCT04215809Recruiting

Study of APG-2575 as a Single Agent or in Combination With Other Therapeutic Agents for CLL/SLL

Assess the safety and tolerability, identify dose-limiting toxicities (DLT) and determine the maximum tolerated dose (MTD) / recommended phase 2 dose (RP2D) of lisaftoclax....

Charlotte, MI144 participantsAscentage Pharma Group Inc.

View Study Details

NCT06945042Recruiting

ONC-LEUK-2406: The Impact of Systematic Financial Navigation in Acute Myeloid Leukemia

The purpose of this research is to see how personal financial burden (financial toxicity) related to cancer affects the overall health and quality of life by evaluating the impact of systematic financ...

Charlotte, MI120 participantsWake Forest University Health Sciences

View Study Details

NCT03555851Recruiting

Factors Affecting Post-transplant Cyclophosphamide (PTCy) Efficacy

This study will examine the influence of donor and recipient pharmacogenetics (PG), drug pharmacokinetics (PK), and T cell phenotypes and how it may permit a tailored dosing strategy to improve the th...

Charlotte, MI120 participantsWake Forest University Health Sciences

View Study Details

NCT07567092Recruiting

A Study of VIRTUGUIDE System and DePuy Synthes Lapidus Implant in Participants Undergoing Lapidus Procedure

The purpose of this study is to assess the surgeon experience and surgery outcomes in participants undergoing index Lapidus procedure for the correction of hallux valgus (a foot deformity where the bi...

Charlotte, MI100 participantsDePuy Synthes Products, Inc.

View Study Details

NCT07024706Recruiting

Phase 2 Study of Disease Risk Mutation-Guided Finite Acalabrutinib+Venetoclax for Relapsed CLL Post-1L Finite cBTKi+BCL2i ± Obinutuzumab

This study will evaluate the efficacy and safety of finite-duration acalabrutinib plus venetoclax therapy in patients with relapsed CLL or SLL, and have previously responded to first line (1L) cBTKi +...

Charlotte, MI80 participantsAstraZeneca

View Study Details

NCT06651970Recruiting

Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure

This will be a global Phase IV, open-label, randomised study to evaluate the safety and tolerability of acalabrutinib (monotherapy, 100 mg orally \[po\], twice daily \[bd\]) compared to investigator's...

Charlotte, MI60 participantsAstraZeneca

View Study Details

NCT06580106Recruiting

Toxicity Genetic Determinants and Response to Azacitidine and Venetoclax in AML

The purpose of this research is to see how certain genetic variations relate to side effects and outcomes experienced while receiving treatment with azacitidine and venetoclax....

Charlotte, MI50 participantsWake Forest University Health Sciences

View Study Details

NCT06680752Recruiting

Clinical Study of ARD103 CAR-T Therapy for Patients With R/R AML or MDS

This is a phase I/2, interventional, open-label, multicenter study to assess the safety and efficacy of ARD103 in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic syndrom...

Charlotte, MI49 participantsARCE Therapeutics, Inc.

View Study Details

NCT06567704Recruiting

Cancer-related Fatigue During Maintenance Immunotherapy for Non-small Cell Lung Cancer (NSCLC): a Qualitative Study

The purpose of this research is to understand cancer related fatigue in patients with non-small cell lung cancer (NSCLC), who are being treated with an immune checkpoint inhibitor....

Charlotte, MI20 participantsWake Forest University Health Sciences

View Study Details

About Leukemia Clinical Trials in Charlotte

Leukemia is a group of blood cancers that develop in the bone marrow and result in abnormal white blood cells. Types include acute myeloid (AML), acute lymphoblastic (ALL), chronic myeloid (CML), and chronic lymphocytic (CLL). Treatment varies by type and may include chemotherapy, targeted therapy, and stem cell transplant.

There are currently 10 leukemia clinical trials recruiting participants in Charlotte, MI. These studies are seeking a combined 1,088 participants. Research is being sponsored by Antares Therapeutics, Inc, Ascentage Pharma Group Inc., Wake Forest University Health Sciences and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Leukemia Clinical Trials in Charlotte — FAQ

Are there leukemia clinical trials in Charlotte?

Yes, there are 10 leukemia clinical trials currently recruiting in Charlotte, MI. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Charlotte?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Charlotte research site will contact you about next steps.

Are clinical trials in Charlotte free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Charlotte studies also compensate for your time and travel.

What leukemia treatments are being tested?

The 10 active trials in Charlotte are testing new therapies including novel drugs, biologics, and treatment approaches for leukemia.

Data updated July 13, 2026 from ClinicalTrials.gov